Vandetanib for the treatment of thyroid cancer: an update.
about
The multi-targeted tyrosine kinase inhibitor vandetanib plays a bifunctional role in non-small cell lung cancer cells.Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy.Thyroid dysfunctions induced by tyrosine kinase inhibitors.The safety of vandetanib for the treatment of thyroid cancer.
P2860
Vandetanib for the treatment of thyroid cancer: an update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vandetanib for the treatment of thyroid cancer: an update.
@en
type
label
Vandetanib for the treatment of thyroid cancer: an update.
@en
prefLabel
Vandetanib for the treatment of thyroid cancer: an update.
@en
P2860
P1476
Vandetanib for the treatment of thyroid cancer: an update.
@en
P2093
Gerasimos E Krassas
Panagiotis Anagnostis
P2860
P304
P356
10.1517/17425255.2014.885015
P407
P577
2014-02-06T00:00:00Z